Seven years ago, a miracle drug, Vosoritide, came on the market. It provided hope for an end to a medical condition called achondroplasia, more commonly known as dwarfism, that affects one in every 25,000 people. Families were told it would make their children significantly taller, as well as treating other medical complications associated with the condition, offering the promise of a more 'normal life'. But has it worked ?